Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article

Advertisement

ResearchIn-Press PreviewEndocrinologyMetabolism Open Access | 10.1172/JCI190765

Hyperinsulinemia-induced upregulation of adipocyte TPH2 contributes to peripheral serotonin production, metabolic dysfunction, and obesity

Brian I. Park,1 Andrew R. Reeves,1 Ying Zhu,1 Robin A. Wilson,1 Sophia C. Fernandes,1 Kimberly K. Buhman,2 Kelli A. Lytle,3 Michael D. Jensen,3 and Andrew S. Greenberg1

1Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, United States of America

2Department of Nutrition Science, Purdue University, West Lafayette, United States of America

3Endocrine Research Unit, Mayo Clinic, Rochester, United States of America

Find articles by Park, B. in: PubMed | Google Scholar

1Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, United States of America

2Department of Nutrition Science, Purdue University, West Lafayette, United States of America

3Endocrine Research Unit, Mayo Clinic, Rochester, United States of America

Find articles by Reeves, A. in: PubMed | Google Scholar

1Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, United States of America

2Department of Nutrition Science, Purdue University, West Lafayette, United States of America

3Endocrine Research Unit, Mayo Clinic, Rochester, United States of America

Find articles by Zhu, Y. in: PubMed | Google Scholar

1Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, United States of America

2Department of Nutrition Science, Purdue University, West Lafayette, United States of America

3Endocrine Research Unit, Mayo Clinic, Rochester, United States of America

Find articles by Wilson, R. in: PubMed | Google Scholar

1Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, United States of America

2Department of Nutrition Science, Purdue University, West Lafayette, United States of America

3Endocrine Research Unit, Mayo Clinic, Rochester, United States of America

Find articles by Fernandes, S. in: PubMed | Google Scholar

1Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, United States of America

2Department of Nutrition Science, Purdue University, West Lafayette, United States of America

3Endocrine Research Unit, Mayo Clinic, Rochester, United States of America

Find articles by Buhman, K. in: PubMed | Google Scholar

1Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, United States of America

2Department of Nutrition Science, Purdue University, West Lafayette, United States of America

3Endocrine Research Unit, Mayo Clinic, Rochester, United States of America

Find articles by Lytle, K. in: PubMed | Google Scholar

1Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, United States of America

2Department of Nutrition Science, Purdue University, West Lafayette, United States of America

3Endocrine Research Unit, Mayo Clinic, Rochester, United States of America

Find articles by Jensen, M. in: PubMed | Google Scholar |

1Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, United States of America

2Department of Nutrition Science, Purdue University, West Lafayette, United States of America

3Endocrine Research Unit, Mayo Clinic, Rochester, United States of America

Find articles by Greenberg, A. in: PubMed | Google Scholar

Published June 2, 2025 - More info

J Clin Invest. https://doi.org/10.1172/JCI190765.
Copyright © 2025, Park et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published June 2, 2025 - Version history
View PDF
Abstract

Tryptophan hydroxylase (TPH) is a rate-limiting enzyme for serotonin or 5-hydroxytryptamine (5-HT) synthesis. Previously, adipocyte TPH1 has been linked to increased adipose 5-HT, reduced BAT thermogenesis, and obesity. However, the role of TPH2, a neural isoform highly expressed in obese adipose tissue, is unknown. Here, we report that adipose tissue expression of TPH2 is significantly elevated in both diet-induced obese (DIO) and ob/ob mice, as well as in obese humans. In high-fat diet (HFD)-fed mice, adipocyte TPH2 deficiency improves DIO-induced metabolic complications, enhances BAT thermogenesis, and increases intestinal energy harvesting efficiency without affecting adiposity. Conversely, TPH2 overexpression in epididymal adipocytes of chow-fed mice raises adipose and plasma 5-HT levels, suppresses BAT thermogenesis, and exacerbates obesity and metabolic dysfunction. We found that obesity-induced hyperinsulinemia upregulates adipocyte TPH2 expression via activation of mechanistic target of rapamycin complex 1 (mTORC1) and sterol regulatory element binding protein 1 (SREBP1). In humans, TPH2 mRNA levels in subcutaneous adipose tissue, but not TPH1, is positively correlated with fasting plasma insulin concentrations. In summary, our study demonstrates that obesity-associated increases in adipocyte TPH2 can regulate distal tissue physiology and energy metabolism, suggesting that TPH2 could be a potential therapeutic target for obesity and its associated complications.

Graphical Abstract
graphical abstract
Supplemental material

View Unedited blot and gel images

View Supplementary table 1

View Supplemental Figure 1

View Supplemental Figure 2

View Supplemental Figure 3

View Supplemental Figure 4

View Supplemental Figure 5

View Supplemental Figure 6

View Supplemental Figure 7

Version history
  • Version 1 (June 2, 2025): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts